The central government has launched ‘Mission Covid Suraksha’ to facilitate the development of around 5-6 Covid-19 vaccines. According to the Department of Biotechnology (DBT) of the Government of India, this will also ensure that, various vaccines are offered for market introduction and licensing. DBT further noted that, this mission focuses on the preclinical phase as well as clinical development, through the manufacturing and regulatory facility to the end of the Kovid-19 vaccine development. Earlier in November 2020, the Government of India announced a third incentive package of Rs 900 crore for the ‘Mission Covid Suraksha – Indian Covid-19 Vaccine Development